Dec 10, 2025 · Monoclonal antibodies can treat autoimmune conditions, cancers and other diseases by working with your immune system.

A monoclonal antibody (mAb, more rarely called moAb) is an antibody produced from a cell lineage made by cloning a unique white blood cell. All subsequent antibodies derived this way trace back to …

Jun 3, 2025 · The mAb (ibritumomab) delivers a radioactive substance (Yttrium-90) directly to cancer cells. Another example is Kadcyla, an mAb that is attached to a chemotherapy drug.

Aug 18, 2025 · According to the World Health Organization (WHO), which is responsible for therapeutic mAb nomenclature, over 800 mAb names have been provided [1]. (See 'Naming conventions' below.)

Bevacizumab (Avastin) is an mAb that targets a protein called VEGF that affects tumor blood vessel growth. It can cause side effects such as high blood pressure, bleeding, poor wound healing, blood …

Monoclonal antibodies (mAb) are important reagents used in biomedical research, in diagnosis of diseases, and in treatment of such diseases as infections and cancer.

A therapeutic monoclonal antibody (mAb) is a homogenous collection of antibodies used to treat an illness. They are selected for their affinity to a target antigen.

Feb 6, 2025 · FDA-approved mAb treatments have been available since the late 1980s. Monoclonal antibody drugs have proven to be more successful at treating certain diseases, such as some …

Jul 23, 2025 · You can often recognize these medicines because their names usually end with the suffix “-mab.” Today, mAbs are becoming popular as both research tools and research targets because …

Immunotherapy via exogenous monoclonal antibody (mAb) administration has been known to treat various central nervous disorders. In the case of AD, immunotherapy is believed to inhibit Aβ …